A New Liquid Biopsy Chip Developed at Worcester Polytechnic institute Detects Circulating Tumor Cells in 100 Percent of Blood Samples from Stage 1-4 Breast Cancer Patients

Using the tendency of circulating cancer cells to adhere to carbon nanotubes, the easily mass-produced chip captures living cells and cell clusters of multiple types and sizes with high reliability and makes them available for analysis. The chip could be used to detect tumors at the earliest stages, before they can metastasize Researchers at Worcester

Read More


The Mitochondrion as an Emerging Therapeutic Target in Cancer

Source https://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(19)30171-6 Mitochondria display a dynamic and heterogeneous phenotype that facilitates the metabolic heterogeneity and plasticity of cancer cells. The altered metabolic functions and dynamics of mitochondria in cancer cells, as well as mitochondrial evasion of apoptosis, provide targets for novel cancer therapeutics. The mitochondrial network has distinct morphological features that appear to be interrelated

Read More


No evidence of added benefit for most new drugs entering German healthcare system

More than half of new drugs entering the German healthcare system have not been shown to add benefit, argue researchers. More than half of new drugs entering the German healthcare system have not been shown to add benefit, argue researchers in The BMJ today. Beate Wieseler and colleagues at the German health technology assessment agency IQWiG (Institute

Read More


Medically tailored meals save lives. Health plans should cover their cost

Source STAT If nutritious meals can provide the same kind of benefit as medication, then why don’t health plans cover the cost of medically tailored meals, just as they cover prescription medications? It’s a question my colleagues and I at Community Servings, a nonprofit organization that provides nutritious meals for people with critical illnesses who are

Read More


Research discovery leads to new clinical trial for myelofibrosis patients

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells. Their study was published in Clinical Cancer Research, a journal of the American Association of Cancer Research. Based on these findings, they

Read More


England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right Simon

Stevens calls for ‘fair prices’ from companies NHS England’s chief executive Simon Stevens was in Manchester this week at the NHS Confederation conference, delivering his latest vision of what lies ahead for the health service. Among his many announcements, he told NHS managers that patient services would have to continue to evolve, and sent a

Read More